If you're looking for a good growth stock to own, you don't have to target a company that's small and in its early growth stages. There is no shortage of larger businesses that generate strong, consistent growth. And the advantage of going with a larger company is that it's often a safer buy given that it will have more of a track record behind it and potentially stronger financials.

Two examples of massive companies that are worth more than $100 billion and that have still managed to double their sales over the past five years are Bristol Myers Squibb (NYSE: BMY) and Amazon (NASDAQ: AMZN). Given their track records, investors should continue to expect more growth from these businesses in the long run.

Pharmaceutical giant Bristol Myers Squibb has a market cap of more than $160 billion and a portfolio of blockbuster drugs that generate more than $1 billion in annual revenue. Two of its top products are cancer medicine Opdivo and blood clot treatment Eliquis, each of which has generated more than $2 billion in sales already in the third quarter alone.

Continue reading

Source Fool.com